Back
Sarepta Therapeutics Vs. Gorman-Rupp Industry Stock Comparison
Buy
55
SRPT
Sarepta Therapeutics
Last Price:
136.34
Seasonality Move:
14.17%
Buy
68
GRC
Gorman-Rupp
Last Price:
32.92
Seasonality Move:
2.86%
Buy
55
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $135.04. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Gorman-Rupp (GRC)
is a Buy
Is Gorman-Rupp a Buy, Sell or Hold?
- The current Gorman-Rupp [GRC] share price is $32.79. The Score for GRC is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- GRC is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $135.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
GRC Stock Price Chart
What is Gorman-Rupp's stock price today?
-
The Gorman-Rupp share price today is $32.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GRC is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.15 | Buy |
Relative Strength Index (14 RSI): | 68.89 | Buy |
Chaikin Money Flow: | 478346 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (119.27 - 130.17) | Buy |
Bollinger Bands (100): | (106.55 - 132.21) | Buy |
GRC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.3 | Sell |
Relative Strength Index (14 RSI): | 33.96 | Sell |
Chaikin Money Flow: | -91249 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.51 - 38.09) | Sell |
Bollinger Bands (100): | (33.66 - 37.68) | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 130.2 | Buy |
20-day SMA: | 124.29 | Buy |
50-day SMA: | 125.73 | Buy |
200-day SMA: | 112.31 | Buy |
8-day EMA: | 130.01 | Buy |
20-day EMA: | 126.71 | Buy |
50-day EMA: | 124.46 | Buy |
200-day EMA: | 116.88 | Buy |
GRC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.73 | Buy |
20-day SMA: | 35.11 | Sell |
50-day SMA: | 36.67 | Sell |
200-day SMA: | 33.59 | Sell |
8-day EMA: | 33.26 | Sell |
20-day EMA: | 34.68 | Sell |
50-day EMA: | 35.72 | Sell |
200-day EMA: | 33.65 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.85 per share, an increase next quarter of $1.52 per share, an increase this year of $5.62 per share, and an increase next year of $6.11 per share.
Gorman-Rupp Earnings Growth & GRC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.08 per share, an increase this year of $0.27 per share, and an increase next year of $0.32 per share.
Sarepta Therapeutics Technical Analysis
Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Gorman-Rupp Technical Analysis
Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |